Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430, (S1530891X24000624), (10.1016/j.eprac.2024.01.016)]
- Yi Hsuan Lin
- , Chia Hung Lin
- , Yu Chih Lin
- , Yu Yao Huang
- , An Shun Tai
- , Shih Chen Fu
- , Sheng Hsuan Lin
Research output: Contribution to journal › Comment/debate › peer-review